Secondary analyses considered the association of selective cox-2 inhibitors ( eg , celecoxib ) , nonselective agents with cox-2 > cox-1 inhibition ( eg , naproxen ) , and nonselective agents with cox-1 > cox-2 inhibition ( eg , ibuprofen ) with the primary outcome .